News Image

NewAmsterdam Pharma Announces Late-Breaking Data from BROADWAY and TANDEM Pivotal Studies Published in Leading Medical Journals and Presented at the European Atherosclerosis Society (EAS) Congress 2025

Provided By GlobeNewswire

Last update: May 7, 2025

– Late Breaking BROADWAY and TANDEM data presented at EAS 2025 and simultaneously published in The New England Journal of Medicine (BROADWAY) and The Lancet (TANDEM) –

Read more at globenewswire.com

NEWAMSTERDAM PHARMA CO NV

NASDAQ:NAMS (10/17/2025, 8:00:01 PM)

After market: 36 -0.4 (-1.1%)

36.4

-0.07 (-0.19%)


NEWAMSTERDAM PHARMA CO NV-27

NASDAQ:NAMSW (10/17/2025, 8:00:01 PM)

24.65

-0.34 (-1.34%)



Find more stocks in the Stock Screener

Follow ChartMill for more